Genenta Science S.p.A.
GNTA · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $42 |
| Gross Profit | $0 | $0 | $0 | -$42 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,455 | $2,772 | $2,040 | $2,553 |
| G&A Expenses | $1,928 | $2,473 | $2,478 | $2,380 |
| SG&A Expenses | $1,928 | $2,473 | $2,478 | $2,380 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,383 | $5,246 | $4,518 | $4,933 |
| Operating Income | -$3,383 | -$5,246 | -$4,518 | -$4,933 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$443 | $372 | $480 | $47 |
| Pre-Tax Income | -$3,827 | -$4,874 | -$4,039 | -$4,886 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,827 | -$4,874 | -$4,039 | -$4,886 |
| % Margin | – | – | – | – |
| EPS | -0.2 | -0.27 | -0.22 | -0.27 |
| % Growth | 25.9% | -22.7% | 18.5% | – |
| EPS Diluted | -0.2 | -0.27 | -0.22 | -0.27 |
| Weighted Avg Shares Out | 18,767 | 18,290 | 18,256 | 18,216 |
| Weighted Avg Shares Out Dil | 18,768 | 18,290 | 18,256 | 18,216 |
| Supplemental Information | – | – | – | – |
| Interest Income | $592 | $0 | $0 | $0 |
| Interest Expense | $427 | $245 | $0 | $0 |
| Depreciation & Amortization | $14 | $22 | $22 | $21 |
| EBITDA | -$3,369 | -$5,224 | -$4,496 | -$4,911 |
| % Margin | – | – | – | – |